Skip to main content

mergers_and_acquisitions

Nutraceutical Ingredients Market to Hit $161.53B by 2031

Nutraceutical Ingredients Market to Hit $161.53B by 2031

Delray Beach, Fla. – September 07, 2026 -- The global nutraceutical ingredients market is set to expand from USD 108.33 billion in 2026 to USD 161.53 billion by 2031, growing at a compound annual rate of 7.3%, according to MarketsandMarkets.

Asia Pacific outpaces global growth with 11.3% CAGR

Asia Pacific is projected to remain the largest and fastest-growing regional market, driven by rising health awareness in China, India, Japan, South Korea, and Australia. Expanding food and beverage manufacturing capacity and growing demand for personalized nutrition are reinforcing the region's supply position.

RedHill Buys Rebyota, Clenpiq Rights From Ferring for $12M

Raleigh, N.C. – September 04, 2026 -- RedHill Biopharma Ltd. (Nasdaq: RDHL) has acquired exclusive global commercialization rights to Ferring Pharmaceuticals' Rebyota and exclusive U.S. rights to Clenpiq, two FDA-approved gastrointestinal drugs that together generated approximately $37.5 million in 2025 net sales.

RedHill pays $12 million upfront, fully funded by prior Talicia sale

Under the agreement, RedHill paid Ferring $12 million upfront plus tiered royalties on net sales and potential future milestones. The payment was fully covered by RedHill's previously announced $18 million divestiture of Talicia, which also carries up to $35 million in potential additional upside. Ferring retains Rebyota's manufacturing facilities and will continue supplying the product through the term of the agreement.